Washington Trust Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Buy |
323
+25
| +8% | +$11.1K | 0.01% | 227 |
|
|
2025
Q1 | $144K | Buy |
298
+59
| +25% | +$28.6K | 0.01% | 220 |
|
|
2024
Q4 | $96.2K | Sell |
239
-69
| -22% | -$27.8K | 0.01% | 261 |
|
|
2024
Q3 | $143K | Sell |
308
-5
| -2% | -$2.32K | 0.01% | 229 |
|
|
2024
Q2 | $147K | Sell |
313
-63
| -17% | -$29.6K | 0.01% | 219 |
|
|
2024
Q1 | $157K | Sell |
376
-161
| -30% | -$67.3K | 0.01% | 212 |
|
|
2023
Q4 | $218K | Sell |
537
-33
| -6% | -$13.4K | 0.02% | 186 |
|
|
2023
Q3 | $198K | Sell |
570
-6
| -1% | -$2.09K | 0.02% | 186 |
|
|
2023
Q2 | $203K | Sell |
576
-128
| -18% | -$45K | 0.02% | 181 |
|
|
2023
Q1 | $222K | Buy |
704
+54
| +8% | +$17K | 0.02% | 171 |
|
|
2022
Q4 | $188K | Sell |
650
-1,575
| -71% | -$455K | 0.02% | 187 |
|
|
2022
Q3 | $644K | Sell |
2,225
-165
| -7% | -$47.8K | 0.06% | 123 |
|
|
2022
Q2 | $673K | Sell |
2,390
-637
| -21% | -$179K | 0.06% | 118 |
|
|
2022
Q1 | $790K | Sell |
3,027
-552
| -15% | -$144K | 0.06% | 123 |
|
|
2021
Q4 | $786K | Buy |
+3,579
| New | +$786K | 0.05% | 131 |
|